
<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  
<!-- Mirrored from investors.scholarrock.com/node/8786/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:09:29 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=UTF-8" /><!-- /Added by HTTrack -->
<head>
    <title>SEC Filing - Scholar Rock, Inc.</title>
    <meta name="robots" content="noindex">
    <link rel="stylesheet" media="all" href="../../sites/g/files/knoqqb56236/files/css/css_-Ogun-b4Vwq8nD6qwBoEYuBhEF_0grnAaUrH4akFvLUcd37.css?delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl" />

    
    <!-- IrwinIQ Tag Manager --> <script> (function(w,d){ var _mtm = w._mtm = w._mtm || []; _mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'}); var g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.src='../../../analytics.imirwin.com/js/container_XFyWYf0m.js'; s.parentNode.insertBefore(g,s); })(window, document); </script> <!-- End IrwinIQ Tag Manager -->

<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-WTGMF33');</script>
<!-- End Google Tag Manager -->

<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="../../../www.googletagmanager.com/nsca0c.html?id=GTM-WTGMF33"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
  </head>
  <body class="body-sidebars-first nir-node nir-node--type-nir-sec-filing nir-node--8786 page-template-default page page-parent wp-custom-logo wp-embed-responsive full-width-content genesis-breadcrumbs-visible genesis-singular-image-hidden genesis-footer-widgets-visible top-parent-investors-media investors-media has-no-blocks elementor-default elementor-page cbp-spmenu-push cookies-set cookies-accepted body_classes" id="body" cz-shortcut-listen="true">
      <div class="region region-content">
    <div id="block-nir-pid2662-websitenoticeblock" class="block--website-notice-block block--website-notice-block--8786 block--content--website-notice-block block--content--website-notice-block--8786 block--24a64b1d-13aa-4b20-8029-2df59f99a96c block--24a64b1d-13aa-4b20-8029-2df59f99a96c--8786 block block-nir-website-notices block-website-notice-block">
  
    
      
  </div>
<div data-drupal-messages-fallback class="hidden"></div>

<div id="block-nir-pid2662-content" class="block--system-main-block block--system-main-block--8786 block--content--system-main-block block--content--system-main-block--8786 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0--8786 block block-system block-system-main-block">
  
    
      <div class="nir-sec-header"><div class="logo"><img src="../../sites/g/files/knoqqb56236/files/Logo.png" alt="Scholar Rock, Inc." />
</div><div class="sec-docs">View:  <div class="field ixbrl-link">
    <a href="ixbrl-viewer"></a>
  </div>
  <div class="file-link">
  <span class="file file--mime-application-rtf file--general"> <a href="../../static-files/0001157523-22-000638.rtf%3b%20filename_%3dUTF-8%27%270001157523-22-000638.rtf" type="application/rtf" title="0001157523-22-000638.rtf">Download DOC</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-pdf file--application-pdf"> <a href="../../static-files/0001157523-22-000638.pdf%3b%20filename_%3dUTF-8%27%270001157523-22-000638.pdf" type="application/pdf" title="0001157523-22-000638.pdf">Download PDF</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-vnd-ms-excel file--x-office-spreadsheet"> <a href="../../static-files/0001157523-22-000638.xls%3b%20filename_%3dUTF-8%27%270001157523-22-000638.xls" type="application/vnd.ms-excel" title="0001157523-22-000638.xls">Download XLS</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-octet-stream file--general"> <a href="../../sec-filings/sec-filing/8-k/0001157523-22-000638.html" type="application/octet-stream" title="0001157523-22-000638-ex-101-sch---xbrl-taxonomy-extension-schema.xsd">Download XBRL</a></span><span class="filesize"> </span>
</div>
</div></div>
    <XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srrk="http://scholarrock.com/20220516" xmlns="../../../www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_519c1ffdba27485a88e3520e6cbdc84c" contextRef="c20220516to20220516" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_efe5e420d7154287a5b43e5435911680" contextRef="c20220516to20220516">0001727196</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="#srrk-20220516.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220516to20220516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001727196</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-16</xbrli:startDate><xbrli:endDate>2022-05-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div>
      <div style="text-align: center;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;">UNITED







          STATES<br />
          SECURITIES AND EXCHANGE COMMISSION</span><br />
        <span style="font-weight: bold;">Washington, D.C. 20549</span><br />
        _____________________</div>

      <div>&#160;</div>

      <div style="text-align: center;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;">FORM







          <ix:nonNumeric name="dei:DocumentType" id="Fact_44e013e814374519a8718564b1ec10c8" contextRef="c20220516to20220516">8-K</ix:nonNumeric></span><br />
        _____________________</div>

      <div>&#160;</div>

      <div style="text-align: center; font-weight: bold;">CURRENT REPORT<br />
      </div>

      <div>&#160;</div>

      <div style="text-align: center; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div>&#160;</div>

      <div style="text-align: center;">Date of Report (Date of earliest event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_608037b2abf345f1b20db48c185a9c8b" contextRef="c20220516to20220516" format="ixt:datemonthdayyearen">May 16, 2022</ix:nonNumeric></div>

      <div>&#160;</div>

      <div style="text-align: center;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_c549ab60b66041d9af361bdd111324f9" contextRef="c20220516to20220516">Scholar Rock Holding Corp</ix:nonNumeric>oration</span><br />
        (Exact Name of Registrant as Specified in Charter)</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_2478279188194af8b949048c8664ce24" contextRef="c20220516to20220516" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_f1fbbe4c5cf54fe687c0e09580f0ad65" contextRef="c20220516to20220516">001-38501</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_d624505f5a9c4de0b8445ad809719af5" contextRef="c20220516to20220516">82-3750435</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center;">(I.R.S. Employer Identification Number)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: center;">
        <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"> <br />
        </div>

        <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_8a74955aff514004aae35611537be247" contextRef="c20220516to20220516">301 Binney Street</ix:nonNumeric><span style="font-weight: bold;">, </span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_130ea2b1bee0412383e00824d93eb80b" contextRef="c20220516to20220516">3rd Floor</ix:nonNumeric><span style="font-weight: bold;">, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_253083ececba40b4b3ab8493ff9864e5" contextRef="c20220516to20220516">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_27ec74618479450dbd7baa5f26dd6e3f" contextRef="c20220516to20220516">MA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_7643e56df8db4e8498e199d07c4aad6e" contextRef="c20220516to20220516">02142</ix:nonNumeric></span></div>
<div>
        (Address of Principal Executive Offices) (Zip Code)</div>
</div>

      <div>&#160;</div>

      <div style="text-align: center;"><span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_2e86a053bff449b0a7e592d8105970f0" contextRef="c20220516to20220516">857</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_377f7744c00f4d6b80b6f30a2915b83e" contextRef="c20220516to20220516">259-3860</ix:nonNumeric></span><br />
        (Registrant&#8217;s telephone number, including area code)</div>

      <div>&#160;</div>

      <div style="text-align: center;">(Former name or former address, if changed since last report)</div>

      <div>&#160;</div>

      <div>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

      <div>&#160;</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_438e6a8422a648ac936ebb1c96ea7cb1" contextRef="c20220516to20220516" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;">&#160; </span>Written communications
        pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_a6aad7f6234c46c1b2dcd6fdc78bb9b5" contextRef="c20220516to20220516" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;">&#160; </span>Soliciting material
        pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_442f67fbb0fe42f89dfb6de0710152d4" contextRef="c20220516to20220516" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;">&#160; </span>Pre-commencement
        communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>

      <div style="text-indent: -18pt; margin-left: 36pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_63dd4d48f57a4d488ec3e3dcdec5445b" contextRef="c20220516to20220516" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160;<span style="text-indent: 0px; font-size: 6pt;">&#160; </span>Pre-commencement
        communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>

      <div>&#160;</div>

      <div>Securities registered pursuant to Section 12(b) of the Act:</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 39.56%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 22%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Trading Symbol(s)</div>
            </td>

    <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 39.56%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_002e815b8b6a4984b219f8808f81b9a8" contextRef="c20220516to20220516">Common Stock, par value $0.001 per share</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 22%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_627e8e1e519e46f48ad62d4eb3a7ed28" contextRef="c20220516to20220516">SRRK</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_4efc6ed3e96d4ad8b2f363ae17761966" contextRef="c20220516to20220516" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div>&#160;</div>

      <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).&#160;Emerging growth company
        <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_bd1705d7f12845d9a3bd332e3fd778e5" contextRef="c20220516to20220516" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>

      <div>&#160;</div>

      <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
        Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_105ab597cb164c55b6727ff9669fc5f4" contextRef="c20220516to20220516" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div><br /></div>

      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 2.02. Results of Operations and Financial Condition.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On May 16, 2022, Scholar Rock Holding Corporation (the &#8220;Company&#8221;) issued a press release announcing its financial and operating results
          for the quarter ended March 31, 2022. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K.</div>

        <div><br />
        </div>

        <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information in this Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed &#8220;filed&#8221;
          for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act
          of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</div>

      </div>

      <div><br />
      </div>

      <div><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01. Financial Statements and Exhibits.</div>

      <div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 7%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">No.</div>
            </td>

    <td style="width: 0.66%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 92%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 0.66%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 92%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="#a52719952ex99_1.htm">99.1</a></div>
            </td>

    <td style="width: 0.66%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 92%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="#a52719952ex99_1.htm">Press Release issued by the Company on
                  May 16, 2022, furnished hereto</a>.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 7%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
            </td>

    <td style="width: 0.66%; vertical-align: middle;">&#160;</td>

    <td style="width: 92%; vertical-align: middle;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div><br />
        <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> <br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Scholar Rock Holding Corporation</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 48%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: May 16, 2022</div>
            </td>

    <td style="width: 2%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
            </td>

    <td style="width: 48%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;">/s/ Junlin Ho</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 48%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Junlin Ho</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 48%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">General Counsel and Corporate Secretary</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div><br />
      </div>

    </div>

  </div>

</body>

<!-- Mirrored from investors.scholarrock.com/node/8786/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:09:29 GMT -->
</html>
</XBRL>
<div><a name="a52719952ex99_1.htm"></a></div><html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div> <br>
  </div>
  <div>
    <div class="bw-release">
      <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>Scholar Rock Reports First Quarter 2022 Financial Results and Updates Strategic Priorities</b> </h1>
      <div class="bw-release-subhead">
        <p style="text-align: center; list-style-position: inside;"><b> <i>- On track for Phase 2 apitegromab TOPAZ two-year data by mid-year</i> </b></p>
        <p style="text-align: center; list-style-position: inside;"><b> <i>- Progressed enrollment for both Phase 3 apitegromab SAPPHIRE clinical trial &amp; Phase 1 SRK-181 DRAGON clinical trial</i> </b></p>
        <p style="text-align: center; list-style-position: inside;"><b> <i>- Restructuring reduces operating expenses, prioritizes R&amp;D activity on completing SAPPHIRE trial and extends cash runway into the fourth quarter of 2023</i> </b></p>
        <p style="text-align: center; list-style-position: inside;"><b> <i>- Yung Chyung, MD, has decided to step down as Chief Medical Officer effective June 30, 2022</i> </b></p>
      </div>
      <div class="bw-release-body">
        <div class="bw-release-table-js bw-release-story">
          <p>CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2022--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today
            provided a business update and reported financial results for the first quarter ended March 31, 2022. </p>
          <p> <b>Business Strategy &amp; Update</b> </p>
          <ul style="list-style-type: disc;">
            <li> <b>Prioritize R&amp;D Activities to Support Progression and Completion of the Apitegromab Phase 3 SAPPHIRE Trial in Spinal Muscular Atrophy. </b>Scholar Rock is focusing its expertise in inhibiting the activation of latent growth factors
              on completing the Phase 2 TOPAZ extension clinical trial and the Phase 3 SAPPHIRE clinical trial, both of which are evaluating the potential of apitegromab to address motor function impairments in patients with spinal muscular atrophy (SMA).
              The SRK-181 program for the treatment of patients with solid tumors showing primary resistance to anti-PD-(L)1 therapy remains a priority with strategic value. While investment in the existing scientific platform continues, the Company is
              narrowing the scope of discovery programs it expects to pursue. </li>
          </ul>
          <ul style="list-style-type: disc;">
            <li> <b>Focused Strategy to Increase Operational Efficiency, Reduce Cash Burn and Extend Runway. </b>The Company today announced a restructuring of its business to prioritize and focus on its clinical stage assets resulting in a reduction to
              its workforce by approximately 25%, in addition to the curtailment of previously planned hiring. The reduction in operating expenses relates to general and administrative spend and research activities related to earlier stage programs. In
              conjunction with the pipeline prioritization, these changes are expected to extend the cash runway into the fourth quarter of 2023. </li>
          </ul>
          <p> &#8220;We are highly confident in the transformative potential of apitegromab based upon the Phase 2 TOPAZ data we have released to date. We look forward to presenting two-year extension trial data in the coming weeks,&#8221; said Nagesh Mahanthappa,
            Ph.D., Founding Chief Executive Officer of Scholar Rock. &#8220;Based upon the strength of the data released to date and our commitment to the SMA community, this narrower focus and associated headcount reduction is necessary to execute our core
            mission -- completing the Phase 3 SAPPHIRE trial to bring apitegromab, our highly innovative therapeutic candidate, to patients suffering with this devastating disease.&#8221; </p>
          <p> Dr. Mahanthappa continued, &#8220;Parting with employees who have dedicated their talent and expertise to evolving a scientific platform into a Phase 3-stage company is very difficult, and we are extremely grateful for their contributions to our
            mission to support patients and help position us to potentially deliver the next big innovation to patients with SMA.&#8221; </p>

          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> <b>Changes to Development Leadership</b> </p>
          <p> The Company also announced today that Yung Chyung, M.D. has decided to step down as Chief Medical Officer (CMO) to explore new career opportunities, including his interest in global health. Dr. Chyung will remain with Scholar Rock through
            June 30 to work with the executive team and the development organization on a transition plan, and a retained search for a new CMO is ongoing. </p>
          <p> &#8220;I am incredibly proud of the progress we&#8217;ve achieved to date at Scholar Rock and am humbled to have served alongside the amazing and talented employees across the company,&#8221; said Dr. Chyung. &#8220;I am enthusiastic about the potential of
            apitegromab and SRK-181 to transform the lives of individuals impacted by serious diseases. With operational momentum continuing to build and the outstanding, high performing teams in place, I feel this is an appropriate time for me to explore
            my other long-term career interests, such as global health.&#8221; </p>
          <p> &#8220;The Board and I sincerely thank Yung for his ingenuity and leadership over the years, which have brought the apitegromab program forward through a successful Phase 2 proof-of-concept study and now into Phase 3, creating hope for patients and
            families suffering from SMA that muscle-directed therapy could have the potential to make a meaningful impact on their lives,&#8221; said Dr. Mahanthappa. &#8220;While the search for a new CMO is a top priority and we are committed to identifying a medical
            leader with a strong track record in late-stage drug development and product launch, the significant depth of talent in our development team allows us to continue to build momentum in the SAPPHIRE pivotal and Phase 1 DRAGON proof-of-concept
            clinical trials without disruption.&#8221; </p>
          <p> <b>Pipeline Updates</b> </p>
          <p> <b>Apitegromab</b> is a selective inhibitor of myostatin activation being developed as the potential first muscle-directed therapy for the treatment of spinal muscular atrophy (SMA). </p>
          <ul style="list-style-type: disc;">
            <li> <b>Enrollment Ongoing for Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Patients with Non-Ambulatory Type 2 and 3 SMA. </b>The randomized, double-blind, placebo-controlled Phase 3 SAPPHIRE clinical trial is evaluating
              apitegromab for patients on either nusinersen or risdiplam. The clinical trial design plans for approximately 156 patients aged 2-12 years old with non-ambulatory Type 2 and 3 SMA to be enrolled in the main efficacy population. </li>
            <li> <b>Clinical Data from the Phase 2 TOPAZ 24-Month Extension Trial to be Presented at Cure SMA Annual Meeting in June</b>. </li>
            <li> <b>Data from the Phase 2 TOPAZ Trial Presented at the Muscular Dystrophy Association (MDA) Clinical &amp; Scientific Conference and the American Academy of Neurology Annual Meeting in March, as well as the European Paediatric Neurology
                Society Congress in April.</b> </li>
          </ul>

          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> <b>SRK-181 </b>is a selective inhibitor of latent TGF&#946;1 activation being developed with the aim of overcoming primary resistance to and increasing the number of patients who may benefit from checkpoint inhibitor therapy. </p>
          <ul style="list-style-type: disc;">
            <li> <b>Enrollment Ongoing for Part B of the Phase 1 DRAGON POC Clinical Trial for SRK-181.</b> Part B consists of multiple proof-of-concept cohorts focused upon evaluating the ability of SRK-181 to overcome primary resistance to anti-PD-(L)1
              therapy. Each cohort will enroll up to 40 patients with various solid tumors, including urothelial carcinoma (UC), cutaneous melanoma (MEL), non-small cell lung cancer (NSCLC), clear cell renal cell carcinoma (ccRCC), and other solid tumors.
              The biomarker strategy in part B of DRAGON will explore early signs of SRK-181 activity, including target engagement and pathway modulation. This will include measuring effects on both circulating and tumor immune contexture, such as CD8+ T
              cell infiltration and reductions in myeloid-derived suppressor cell (MDSC) populations as well as analysis of TGF&#946;-related pathway signaling. Initial evidence of drug activity and safety data are anticipated in 2022. </li>
          </ul>
          <p> <b>First Quarter 2022 Financial Results</b> </p>
          <p> For the quarter ended March 31, 2022, net loss was $8.0 million or $0.21 per share compared to a net loss of $27.7 million or $0.76 per share for the quarter ended March 31, 2021. </p>
          <ul style="list-style-type: disc;">
            <li> Revenue was $33.2 million for the quarter ended March 31, 2022 compared to $4.7 million for the quarter ended March 31, 2021 and was related to the Gilead fibrosis-focused research collaboration, which was executed in December 2018 and
              concluded in December 2021. </li>
            <li> Research and development expense was $29.4 million for the quarter ended March 31, 2022 compared to $22.5 million for the quarter ended March 31, 2021. The increase year-over-year primarily reflects increased clinical costs associated with
              apitegromab and higher personnel costs. The Company expects research expenses to decline beginning in the third quarter of 2022 due to the portfolio updates and workforce reduction announced today. </li>
            <li> General and administrative expense was $10.8 million for the quarter ended March 31, 2022 compared to $9.4 million for the quarter ended March 31, 2021. The increase year-over-year was primarily attributed to higher personnel costs. As a
              result of our reduction in force, we expect our employee-related expenses to decline in the second half of the year as compared to the first half of 2022. </li>
            <li> As of March 31, 2022, Scholar Rock had cash, cash equivalents, and marketable securities of approximately $210 million. The Company expects that the updates and changes announced today will fund its anticipated operating and capital
              expenditure requirements into the fourth quarter of 2023. </li>
          </ul>
          <p> &#8220;While we have paused many of our discovery programs, we are continuing to progress selected pre-clinical programs which best exemplify the value of our platform. As a platform company, business development remains an important part of our
            strategy and we continue to explore partnerships for these programs which could be a source of non-dilutive capital in the future,&#8221; said Ted Myles, Chief Operating Officer and Chief Financial Officer at Scholar Rock. &#8220;Our streamlined focus and
            structure allow us to channel the majority of our resources to supporting the SAPPHIRE trial and SRK-181, which we believe are key near- and long-term value drivers.&#8221; </p>

          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> <b>About Scholar Rock</b> </p>
          <p> Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar
            Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock&#8217;s approach to
            targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular
            level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on
            biologically validated growth factors may facilitate a more efficient development path. For more information, please visit www.ScholarRock.com or follow Scholar Rock on Twitter (@ScholarRock) and LinkedIn
            (https://www.linkedin.com/company/scholar-rock/). Investors and others should note that we communicate with our investors and the public using our company website www.scholarrock.com, including, but not limited to, company disclosures, investor
            presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on Twitter and LinkedIn. The information that we post on our website or on Twitter or
            LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be
            deemed incorporated by reference in any filing under the Securities Act of 1933, as amended. </p>
          <p> Scholar Rock&#174; is a registered trademark of Scholar Rock, Inc. </p>
          <p> <b>Forward-Looking Statements</b> </p>
          <p> This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Scholar Rock&#8217;s future expectations, plans and prospects,
            including without limitation, Scholar Rock&#8217;s expectations regarding its growth, strategy, progress and timing of its clinical trials for apitegromab, SRK-181, and other product candidates and indication selection and development timing, its
            cash runway, the ability of any product candidate to perform in humans in a manner consistent with earlier nonclinical, preclinical or clinical trial data, and the potential of its product candidates and proprietary platform.<i> </i>The use of
            words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;future,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; and other similar expressions are intended to identify such
            forward-looking statements. All such forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and
            adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, without limitation, that preclinical and clinical data, including the results from the Phase 2 clinical trial of
            apitegromab, or Part A of the Phase 1 clinical trial of SRK-181, are not predictive of, may be inconsistent with, or more favorable than, additional data generated from clinical trials of the same product candidate, including, without
            limitation, the TOPAZ extension clinical trial and the Phase 3 SAPPHIRE clinical trial of apitegromab in SMA or Part B of the Phase 1 DRAGON clinical trial of SRK-181, Scholar Rock&#8217;s ability to provide the financial support, resources and
            expertise necessary to identify and develop product candidates on the expected timeline, the data generated from Scholar Rock&#8217;s nonclinical and preclinical studies and clinical trials, information provided or decisions made by regulatory
            authorities, competition from third parties that are developing products for similar uses, Scholar Rock&#8217;s ability to obtain, maintain and protect its intellectual property, Scholar Rock&#8217;s dependence on third parties for development and
            manufacture of product candidates including, without limitation, to supply any clinical trials, Scholar Rock&#8217;s ability to manage expenses and to obtain additional funding when needed to support its business activities and establish and maintain
            strategic business alliances and new business initiatives, and the impacts of public health pandemics such as COVID-19 on business operations and expectations, as well as those risks more fully discussed in the section entitled "Risk Factors"
            in Scholar Rock&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, as well as discussions of potential risks, uncertainties, and other important factors in Scholar Rock&#8217;s subsequent filings with the Securities and Exchange
            Commission. Any forward-looking statements represent Scholar Rock&#8217;s views only as of today and should not be relied upon as representing its views as of any subsequent date. All information in this press release is as of the date of the
            release, and Scholar Rock undertakes no duty to update this information unless required by law. </p>

          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <table cellspacing="0" id="z09edb04816d240ffbae3a656521c1fb2" style="margin-bottom: 10px;margin-left: 0px; margin-right: auto; font-size: 10pt;">

              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="8">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Scholar Rock Holding Corporation</b> </p>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="8">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Condensed Consolidated Statements of Operations</b> </p>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="8">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (unaudited) </p>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="8">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (in thousands, except share and per share data) </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;padding-left: 0px;white-space: nowrap;" colspan="7">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Three Months Ended March 31</b> </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;white-space: nowrap;" colspan="3">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: center; list-style-position: inside;"> <b>2022</b> </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;white-space: nowrap;">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;white-space: nowrap;" colspan="3">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: center; list-style-position: inside;"> <b>2021</b> </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Revenue</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 33,193 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 4,708 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Operating expenses</td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Research and development</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 29,366 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 22,549 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">General and administrative</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 10,760 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 9,366 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Total operating expenses</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 40,126 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 31,915 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Loss from operations</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (6,933 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (27,207 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Other income (expense), net</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (1,017 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (464 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Net loss</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (7,950 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (27,671 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Net loss per share, basic and diluted</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (0.21 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (0.76 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> ) </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Weighted average common shares outstanding, basic and diluted</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 37,456,574 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 36,380,438 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="margin-bottom: 0px; margin-top: 0px;text-align: left;"> &#160; </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="3">&#160;</td>
              </tr>

          </table>

          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <table cellspacing="0" id="z4817c92c23ec47a891175d715af9cd81" style="margin-bottom: 10px;margin-left: 0px; margin-right: auto; font-size: 10pt;">

              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="6">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Scholar Rock Holding Corporation</b> </p>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="6">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>Condensed Consolidated Balance Sheets</b> </p>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="6">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (unaudited) </p>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;text-align: center; list-style-position: inside;" colspan="6">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> (in thousands) </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" colspan="2" style="text-align: center; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" colspan="2" style="text-align: center; list-style-position: inside;vertical-align: bottom;padding-left: 0px;">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;white-space: nowrap;" colspan="2">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>March 31, 2022</b> </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;padding-left: 0px;white-space: nowrap;">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td rowspan="1" style="text-align: center; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;white-space: nowrap;" colspan="2">
                  <p style="text-align: center; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> <b>December 31, 2021</b> </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><b>Assets</b></td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                </td>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" style="vertical-align: bottom;padding-left: 0px;" colspan="2"><br>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Cash, cash equivalents and marketable securities</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 210,211 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 252,994 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Other current assets</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 18,375 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 12,325 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Total current assets</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 228,586 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 265,319 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Other assets</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 37,391 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 39,126 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Total assets</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 265,977 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 304,445 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" colspan="2" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" colspan="2" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;"><b>Liabilities and Stockholders' Equity</b></td>
                <td rowspan="1" colspan="2" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td rowspan="1" colspan="2" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Current liabilities</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 33,373 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 64,297 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Long-term liabilities</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 61,288 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 68,074 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Total liabilities</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 94,661 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: solid black 1pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 132,371 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 20px;">Total stockholders' equity</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 171,316 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;border-bottom: solid black 1pt;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 172,074 </p>
                </td>
              </tr>
              <tr>
                <td colspan="1" rowspan="1" style="vertical-align: bottom;padding-left: 0px;">Total liabilities and stockholders' equity</td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 265,977 </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;padding-left: 0px;"><br>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> $ </p>
                </td>
                <td colspan="1" rowspan="1" style="text-align: right; list-style-position: inside;vertical-align: bottom;border-bottom: double black 2.25pt;padding-left: 0px;padding-right: 0px;">
                  <p style="text-align: right; list-style-position: inside;margin-bottom: 0px; margin-top: 0px;"> 304,445 </p>
                </td>
              </tr>

          </table>
          <p> &#160; </p>
        </div>
        <div class="bw-release-contact">
          <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
          <p> <b>Scholar Rock Contacts: </b><br>
            <b>Investors </b><br>
            Rushmie Nofsinger <br>
            Scholar Rock <br>
            ir@scholarrock.com<br>
            857-259-5573 </p>
          <p> <b>Media </b><br>
            Ariane Lovell <br>
            Finn Partners <br>
            ariane.lovell@finnpartners.com<br>
            media@scholarrock.com<br>
            917-565-2204 </p>
        </div>
      </div>
    </div>
  </div>
</body>
</html>


  </div>

  </div>

          <script type="text/javascript">var s_CCSWebHostingAccount = "trcgscholarrock";</script>
        <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/8786\/html","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","themeUrl":"sites\/g\/files\/knoqqb56236\/themes\/site\/nir_pid2662"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"user":{"uid":0,"permissionsHash":"4506f7b957b4baf2488ee006e9b884f3b49293f46cfb6e03ffbb15fedba12da4"}}</script>
<script src="../../sites/g/files/knoqqb56236/files/js/js_D31miEwayYNfIODJWy2ump8i_gwklTzvOKq4eFgXiKw4996.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl"></script>
<script src="../../../assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js" crossorigin="anonymous" async integrity="sha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf"></script>

  </body>
</html>
